Finally got together on March 30, 2021 with these amazing cancer researchers of The University of Toledo, celebrating Dr. Amit Tiwari's $1.4 million DOD grant fund awarded to continue their preclinical study to have a better understanding of how the chemical structure of his promising drug discovery targets a certain protein to induce cancer cell death in Triple Negative Breast Cancer (TNBC) cells.As a patient advocate, I am excited to share with our TNBC Community, Dr. Tiwari has discovered a compound that causes a unique cancer cell death where the cells swell and burst. With this approach, markers are released that signals the body's immune system to target and destroy even the most resistant Triple Negative Breast Cancer cells. Thus far, this has been proven effective in mice models and human cancer cells in the lab.
Dr. Tiwari's compound discovery of overcoming multi-drug resistance that has often been seen in Triple Negative Breast Cancer, brings much hope to us TNBC survivors. We need to continue to support Dr. Tiwari and his team to advance their research to human clinical trials. We so need better treatment options when current chemotherapy treatments stops working.
 |
| Dr. Raman, Dr. Tang, Melissa and Dr. Tiwari |
"Thank you Melissa for sharing our wonderful meeting with you, Drs. Raman and Tang. They were equally delighted to meet you. Thank you for community outreach and being an integral part of our team. We are blessed to have you." - Dr. Amit K. Tiwari
